A unique spectrum of p53 mutations in B-cell chronic lymphocytic leukemia distinct from that of other lymphoid malignancies

被引:16
作者
Newcomb, EW [1 ]
ElRouby, S [1 ]
Thomas, A [1 ]
机构
[1] KAPLAN COMPREHENS CANC CTR,NEW YORK,NY 10016
关键词
tumor suppressor gene; p53; environmental carcinogens;
D O I
10.1002/mc.2940140402
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The spectrum and pattern of p53 mutations detected in 42 cases of B-cell chronic lymphocytic leukemia (B-CLL) were analyzed, and several interesting features were noted. Codon 209 in the p53 gene may be a new hot-spot for p53 mutation in B-CLL disease. Four of the 42 (10%) reported B-CLL p53 mutations occurred at codon 209 versus none in 214 cases of other lymphoid malignancies screened for p53 mutations (P = 0.0006). Transversion mutations predominated at codon 273 rather than the transition mutations that are known to occur at this CpG site. Four of six (67%) B-CLL cases had transversions at codon 273 compared with two of 17 (12%) of all other lymphoid tumors examined (P = 0.02). In addition, over 65% of the p53 mutations detected in B-CLL showed a strand bias for p53 mutations on the untranscribed DNA strand. This feature of DNA strand bias is notable in cancers of the lung, esophagus, and head and neck, which may result from high exposure to carcinogens. This spectrum of p53 mutations in B-CLL together with the high frequency of transversion mutations and DNA strand bias may implicate environmental carcinogens associated with p53 gene damage in some B-CLL patients. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 64 条
[1]   THE SPECTRUM OF MOLECULAR ALTERATIONS IN THE EVOLUTION OF CHRONIC MYELOCYTIC-LEUKEMIA [J].
AHUJA, H ;
BARELI, M ;
ARLIN, Z ;
ADVANI, S ;
ALLEN, SL ;
GOLDMAN, J ;
SNYDER, D ;
FOTI, A ;
CLINE, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2042-2047
[2]  
ANAKAI H, 1993, LEUKEMIA, V10, P1547
[3]  
BALLERINI P, 1993, BLOOD, V81, P166
[4]  
BHATIA KG, 1992, CANCER RES, V52, P4273
[5]  
BUHLERLECLERC M, 1993, BRIT J HAEMATOL, V84, P443
[6]  
CESARMAN E, 1993, AM J PATHOL, V143, P845
[7]  
CESARMAN E, 1992, BLOOD, V80, P3205
[8]  
DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1
[9]   P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS [J].
DOHNER, H ;
FISCHER, K ;
BENTZ, M ;
HANSEN, K ;
BENNER, A ;
CABOT, G ;
DIEHL, D ;
SCHLENK, R ;
COY, J ;
STILGENBAUER, S ;
VOLKMANN, M ;
GALLE, PR ;
POUSTKA, A ;
HUNSTEIN, W ;
LICHTER, P .
BLOOD, 1995, 85 (06) :1580-1589
[10]  
el Rouby S, 1992, Curr Top Microbiol Immunol, V182, P313